Detalhe da pesquisa
1.
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS.
Cell
; 172(4): 857-868.e15, 2018 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29336889
2.
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.
Cell
; 150(6): 1107-20, 2012 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22980975
3.
Evaluation of grade in a genotyped cohort of sporadic medullary thyroid carcinomas.
Histopathology
; 79(3): 427-436, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33763905
4.
Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia model.
Haematologica
; 106(5): 1330-1342, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538148
5.
Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors.
Proc Natl Acad Sci U S A
; 111(45): E4869-77, 2014 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25349422
6.
Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance.
Proc Natl Acad Sci U S A
; 110(42): 17041-6, 2013 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24085845
7.
Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients.
Blood
; 132(24): 2608-2612, 2018 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30366921
8.
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M.
Nature
; 462(7276): 1070-4, 2009 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-20033049
9.
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study.
Thyroid
; 34(2): 167-176, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37842841
10.
Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.
N Engl J Med
; 363(18): 1727-33, 2010 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-20979472
11.
Dimorphic glioblastoma with glial and epithelioid phenotypes: Clonal evolution and immune selection.
Front Neurol
; 13: 1017087, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36703629
12.
Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations.
Mol Oncol
; 15(1): 27-42, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32191822
13.
Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma.
Nat Cancer
; 1(5): 493-506, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33409501
14.
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant.
Nat Commun
; 11(1): 2996, 2020 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32533060
15.
Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myeloma.
Leukemia
; 33(1): 266-270, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30026571
16.
Buccal mucosa cells as in vivo model to evaluate gefitinib activity in patients with advanced non small cell lung cancer.
Clin Cancer Res
; 13(21): 6518-26, 2007 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17975165
17.
Refractory pleural small cell carcinoma in never smoker. A case report.
Tumori
; 94(3): 434-6, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18705417
18.
Profiling of circulating exosomal miRNAs in patients with Waldenström Macroglobulinemia.
PLoS One
; 13(10): e0204589, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30286096
19.
Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche.
Leukemia
; 32(8): 1739-1750, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29925904
20.
Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non-Small Cell Lung Cancer.
Clin Cancer Res
; 24(23): 5963-5976, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30072474